Beijing Kinghawk Pharmaceutical Co., Ltd. of Beijing at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers

Beijing Kinghawk Pharmaceutical Co., Ltd.

No. 7 Yuncheng St., Beijing Economic, Technological Development Area, 100176 Beijing
China
Telephone +86 10 67878866
Fax +86 10 67871632
daniel@kinghawk828.com

This company is co-exhibitor of
Messe Duesseldorf China Ltd.

Hall map

MEDICA 2018 hall map (Hall 7, level 1): stand H08

Fairground map

MEDICA 2018 fairground map: Hall 7, level 1

Our range of products

Product categories

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)

Our products

Product category: Polymerase chain reaction (PCR)

Diagnostic Kit for Antigen/Antibody to Human Immunodeficiency Virus(ELISA)

This kit is designed to detect antibodies against Human Immunodeficiency Virus (HIV) (subtype M-O of Type I and Type II) and P24 antigens in human serum and plasma. It is applied to test of blood products, to screen donors, and to assist the diagnosis of the infection of HIV.

Applying the sandwich method, ELISA plates are coated with engineered HIV antigens (i.e. gp41 & gp36) and P24 monoclonal antibody which are used to capture the antigen/antibody in serum or plasma. Biotin labeled P24 polyclonal antibody, enzyme labeled engineered antigen and enzyme labeled streptavidin are subsequently added to form the sandwich complex which are developed in TMB substrate system. OD value which is read by spectrophotometer shows whether HIV Type 1+2 Ab/Ag presents in samples.

More Less

About us

Company details

Beijing Kinghawk Pharmaceutical Co., Ltd (‘Kinghawk Pharmaceutical’ for short) is a high-tech enterprise specializing in bio-technology and product development. With registered capital of 42 million Yuan, founded in 1993 and located in the unique state-level development zones of Beijing, Beijing Economic and Technological Development Area, known as the ‘Beijing Medicine canyon’, Kinghawk Pharmaceutical covers 6000 m2, the company is certified by the “Good Manufacturing Practice”(GMP) and ISO13485:2003, ISO9001:2008, the company successful listing at ZhongGuanCun third board in Beijing(Stock Short Name: Kinghawk pharmaceutical, Stock Code: 430026) and joined into Beijing “G20” project .The CCAP Test Center has passed the evaluation of China National Accreditation Service for Conformity Assessment(CNAS)and received the ISO 17025 certification in 2012.

Since Kinghawk established, in line with the Spirit of forge ahead, realistic and innovative, Kinghawk has developed 150 in vitro diagnostic kits covering the Colloidal ,ELISA, Blood Grouping,  PCR, CLIA, Clinical Chemistry, and Standard Reference. We own 6 production lines of colloidal , ELISA,PCR, blood grouping ,clinical chemistry and standard reference. Kinghawk has successfully  established the domestic first-class operation platform of information, scientific, research, production, sales and training, in the same time, Kinghawk has established a good technical exchanges and cooperation between enterprises and research institutions from domestic and abroad.

Kinghawk Pharmaceuticalpursues the “pursuit of excellence,dedication to society” business purposes; adhere to the “integrity, rigorous,diligent,
innovation”corporate philosophy. Dedicate to the health of human beings and stop disease transmission.

More Less